Question 1

What is Emmecell?

Accepted Answer

Emmecell is a privately held, clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for the treatment of eye diseases via its exclusive Magnetic Cell Delivery (MCD) nanoparticle platform technology.

Question 2

What is Emmecell's Magnetic Cell Delivery (MCD) platform?

Accepted Answer

Emmecell's proprietary MCD nanoparticle platform leverages magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue, solving the challenges of delivery, retention, and integration of cell therapies.

Question 3

What is the focus of Emmecell's initial efforts?

Accepted Answer

Emmecell is focusing its initial efforts on ophthalmic indications using its MCD platform to bring innovative regenerative medicine out of the laboratory and into patient care.

Question 4

What services does CellMP provide?

Accepted Answer

CellMP, a subsidiary of Emmecell, provides research, current good manufacturing practices (cGMP) manufacturing, and testing services to biotechnology startups.

Question 5

What is Emmecell's mission?

Accepted Answer

Emmecell's mission is to bring innovative regenerative medicine out of the laboratory and into patient care.

Emmecell

Company Overview

Company Name

Address

Website

Employees

About Emmecell

Frequently Asked Questions about Emmecell

What is Emmecell?

What is Emmecell's Magnetic Cell Delivery (MCD) platform?

What is the focus of Emmecell's initial efforts?

What services does CellMP provide?

What is Emmecell's mission?

Technologies Used

Key Decision Makers